USPTO Issues Hemp Guidance

Earlier this month, the United States Patent and Trademark Office (“USPTO”) released an official examination guide in response to the Agricultural Improvement Act of 2018 (“2018 Farm Bill”) and associated applications. While the guide offers some clarity for the federal registration of trademarks … Read more about USPTO Issues Hemp Guidance

TTB Rejects Use of CBD in Alcohol Beverages

The U.S. Alcohol and Tobacco Tax and Trade Bureau ("TTB") has joined the discussion regarding the legality of hemp and hemp-derived additives in consumable items. In a bureau-wide bulletin, the agency addressed wineries, distilleries, breweries, and importers hoping to add ingredients like … Read more about TTB Rejects Use of CBD in Alcohol Beverages

Psychedelic Medicine’s Rise in 2019

Late March of 2019, a collection of European technology investors made waves in the psychedelic medicine industry, amassing the largest-ever private financing round for biotech company, ATAI Life Sciences (“ATAI”). According to ATAI’s press release, the German-based company’s Series B financing … Read more about Psychedelic Medicine’s Rise in 2019

The Agricultural Improvement Act of 2018 & Federal Trademarks

Securing federal trademark protection for products derived from industrial hemp has proven to be a challenge for many in the industry. The United States Patent and Trademark Office (the “USPTO) categorically denies any trademark application that is submitted for an “illegal” product or service.1 Up … Read more about The Agricultural Improvement Act of 2018 & Federal Trademarks

Industrial Hemp Definition on Ballot in CO

This November, voters in Colorado will be asked to decide on Amendment X, which reads: “Shall there be an amendment to the Colorado constitution concerning changing the industrial hemp definition from a constitutional definition to a statutory definition?” Colorado is the only state in the country … Read more about Industrial Hemp Definition on Ballot in CO

DEA Reschedules CBD-Based Epidiolex

The Drug Enforcement Administration (DEA) has rescheduled the cannabidiol (CBD) based drug Epidolex, but limited the rescheduling to exclude all CBD products. Epidiolex will be scheduled at Schedule 5, the lowest level of drug scheduling under the Controlled Substances Act (CSA). Epidiolex, … Read more about DEA Reschedules CBD-Based Epidiolex

CBD in Food? California Says No Way, (San) Jose.

In a blow to hemp-derived cannabidiol (CBD) product manufacturers who intend to use CBD as a food additive, the California Department of Public Health (CDPH), in conjunction with the California Food and Drug Branch (FDB), has released a clarification document titled: "FAQ - Industrial Hemp and … Read more about CBD in Food? California Says No Way, (San) Jose.

STATES Act a Game Changer for Cannabis

On June 7, 2018, Senators Elizabeth Warren (Democrat - Massachusetts) and Cory Gardner (Republican - Colorado) introduced bipartisan legislation that would allow states to regulate cannabis without incurring any federal interference. The Strengthening the Tenth Amendment Through Entrusting States … Read more about STATES Act a Game Changer for Cannabis